Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Filana Therapeutics Inc., 3 years.
Filana Therapeutics Inc.
Director · President & CEO
Sarepta Therapeutics Inc.
Director
Chief executive roles
Filana Therapeutics Inc.
· President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 23, 2024 | Filana Therapeutics Inc. | Option exercise | +176,085 | $22.00 | $3,873,870 |
| Mar 1, 2024 | Sarepta Therapeutics Inc. | Grant or award | +1,846 | — | — |
| Nov 3, 2023 | Sarepta Therapeutics Inc. | Open-market purchase | +10,000 | $78.81 | $788,100 |
| Nov 3, 2023 | Sarepta Therapeutics Inc. | Open-market purchase | +40,000 | $78.81 | $3,152,400 |
| Aug 22, 2023 | Filana Therapeutics Inc. | Open-market purchase | +16,571 | $16.65 | $275,907 |
| Aug 21, 2023 | Filana Therapeutics Inc. | Open-market purchase | +1,906 | $16.80 | $32,021 |
| Mar 7, 2023 | Filana Therapeutics Inc. | Open-market purchase | +77,276 | $25.76 | $1,990,630 |
| Mar 6, 2023 | Sarepta Therapeutics Inc. | Grant or award | +1,523 | — | — |
| Mar 6, 2023 | Filana Therapeutics Inc. | Open-market purchase | +11,565 | $26.13 | $302,193 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.